PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Dual-function molecule could unlock smarter treatments for kidney disease

Study finds the molecule CCL5 is both protective and harmful, suggesting future drugs could target only its damaging effects

2025-10-23
(Press-News.org)

Chronic kidney disease (CKD) is a progressive condition in which the kidneys gradually lose their ability to filter waste from the blood. It is a common health concern that affects an estimated 8–16% of the global population, particularly among older adults. CKD can arise from various causes, including glomerulonephritis, a group of diseases that damage the glomeruli, the tiny filtering units within the kidneys.

 

Now, researchers from Chiba University have identified a molecule called C-C chemokine ligand 5 (CCL5) as a key player in kidney injury and repair. Their findings reveal that CCL5 behaves in two distinct ways: it can protect certain kidney cells, called podocytes, which are specialized cells that wrap around the glomerulus and form the final barrier of the kidney filter; however, at the same time, it can exacerbate overall kidney damage.

 

The study was led by Professor Katsuhiko Asanuma of the Graduate School of Medicine, Chiba University, Japan, together with Professor Motoko Y. Kimura and Lecturer Ryo Koyama-Nasu of the Graduate School of Medicine, Chiba University, as well as Ika N. Kadariswantiningsih, Issei Okunaga, and Kaho Yamasaki from the Graduate School of Medicine and Pharmaceutical Sciences, Chiba University. Their findings, published online on September 23, 2025, in JCI Insight, a journal of the American Society for Clinical Investigation, may pave the way for more precise treatments for CKD.

 

CCL5 is a signaling molecule, or chemokine, that helps immune cells move toward sites of inflammation. It was first identified in T cells, but later research showed that it is also produced by other cell types, including epithelial cells around the glomeruli known as podocytes, which act as the final layer of filtration. As a result, CCL5 plays both helpful and harmful roles, supporting immune defense on one hand but promoting inflammation and tissue damage on the other.

 

Previous studies produced conflicting results about the effects of CCL5, with some suggesting that it protects the kidneys, while others indicated that it worsens injury. To clarify CCL5’s role in CKD, the Chiba University team analyzed kidney tissue from patients with various glomerular diseases and from mice with Adriamycin (ADR)-induced nephropathy, a model that closely mimics human kidney disorders such as focal segmental glomerulosclerosis.

 

In both humans and mice, they found that CCL5 levels were much higher in damaged glomeruli and were closely linked to podocytes, the cells that maintain the filtration barrier.

 

Next, the researchers carried out experiments using both laboratory-grown podocytes and live mice. In the lab, treating podocytes with CCL5 helped them survive and reduced cell death, suggesting a protective effect. However, in the mice, which developed kidney disease, higher CCL5 levels exacerbated damage, causing more protein to leak into the urine, more scarring of kidney tissue, and greater loss of podocytes.

 

To understand why this happened, the team examined the role of immune cells. When they transplanted bone marrow from mice lacking CCL5 into normal mice, the recipients showed reduced kidney damage. This indicated that CCL5 produced by immune cells, rather than kidney cells, was responsible for worsening the disease. Further analysis showed that CCL5 promoted inflammatory ‘M1’ macrophages while reducing the number of healing ‘M2’ macrophages. In other words, it shifted the balance toward inflammation rather than repair. “The harmful immune effects of CCL5 outweigh its protective role in podocytes, leading to proteinuria, glomerulosclerosis, and podocyte loss,” explains Prof. Asanuma.

 

These results highlight a new approach for developing future treatments for CKD. Instead of broadly blocking inflammatory pathways, therapies could be designed to support the body’s own repair mechanisms while limiting the harmful immune responses that cause kidney damage.

 

“The insights gained from CCL5’s dual role could guide the development of cell-targeted drugs that block its harmful immune effects without interfering with its protective actions in podocytes. If such therapies become available, patients could benefit from slower CKD progression, fewer cases requiring dialysis or transplantation, and better preservation of kidney function and quality of life,” says Prof. Asanuma.

 

To see more news from Chiba University, click here.

 

About Professor Katsuhiko Asanuma from Chiba University, Japan
Katsuhiko Asanuma is a Professor in the Department of Nephrology at the Graduate School of Medicine, Chiba University, Japan. His research focuses on understanding the mechanisms that drive chronic kidney disease and developing new treatments to prevent its progression. In addition to laboratory research, he also conducts clinical studies on patient education, rehabilitation, and AI-assisted care for dialysis patients, aiming to improve kidney health and reduce dialysis dependency in Japan.

 

END



ELSE PRESS RELEASES FROM THIS DATE:

Dementia linked to problems with brain’s waste clearance system

2025-10-23
Problems with the brain’s waste clearance system could underlie many cases of dementia and help explain why poor sleep patterns and cardiovascular risk factors such as high blood pressure increase the risk of dementia. A study led by researchers at the University of Cambridge found that impaired movement of cerebrospinal fluid (CSF) – the clear liquid that cushions and cleans the brain – predicted risk of dementia later in life among 40,000 adults recruited to the UK Biobank. Their findings are published today in Alzheimer's & Dementia: The Journal of the Alzheimer's Association. In the healthy ...

Psoriasis-linked gene mutation also impacts gut health

2025-10-23
Ghent, 23 October 2025 – A mutation previously linked to skin disorders like psoriasis may also play a surprising role in gut health, according to new research published by scientists at VIB-UGent and colleagues from UGent, the University of Barcelona, and University College London. This mutation activates skin immune responses but also affects the intestine. This finding, published in EMBO Molecular Medicine, reveals a new connection between genetics, the immune system, and the gut, which may have therapeutical implications.   Scientists under the leadership of Dr. Inna ...

Widely-used technique for assessing IVF embryos may be flawed, study suggests

2025-10-23
A test deployed in many fertility clinics to assess the viability of embryos for use in IVF is likely to overestimate the number of embryos with abnormalities, suggests a study published today. Using a new technique for imaging embryos in real time, a team led by scientists at the Loke Centre for Trophoblast Research, University of Cambridge, showed that abnormalities can arise at a later stage of embryo development than previously thought. This means that the tests used in some clinics may be finding errors in cells that will go on to develop into the placenta – and abnormalities in placental cells are less likely to affect the health of the fetus. When an egg has been ...

Alzheimer’s disrupts circadian rhythms of plaque-clearing brain cells

2025-10-23
Alzheimer’s disease is notorious for scrambling patients’ daily rhythms. Restless nights with little sleep and increased napping during the day are early indicators of disease onset, while sundowning, or confusion later in the day, is typical for later stages of the disease. These symptoms suggest a link between the progression of the disease and the circadian system — the body’s internal clock that controls our sleep and wake cycle — but scientists did not know the full nature of the connection. Researchers from Washington University School of Medicine in St. Louis ...

Nanoparticle blueprints reveal path to smarter medicines

2025-10-23
Lipid nanoparticles (LNPs) are the delivery vehicles of modern medicine, carrying cancer drugs, gene therapies and vaccines into cells. Until recently, many scientists assumed that all LNPs followed more or less the same blueprint, like a fleet of trucks built from the same design.  Now, in Nature Biotechnology, researchers from the University of Pennsylvania, Brookhaven National Laboratory and Waters Corporation have characterized the shape and structure of LNPs in unprecedented detail, revealing that the particles come in a surprising variety of configurations. ...

Researchers get wind of hydrogen’s role in the gut

2025-10-23
Key points  Hydrogen gas is produced in the gut, with some expelled as flatulence Researchers have shed new light on how gut microbes make and use hydrogen This will help in understanding and maintaining overall gut health Farts are causing a stink in the research world, but in a positive way. Melbourne scientists have revealed how hydrogen is made and used in the human gut. Though infamous for making farts ignite, hydrogen also has a positive role supporting gut health. In this study published in Nature Microbiology, ...

Supersolid spins into synchrony

2025-10-23
A supersolid is a paradoxical state of matter—it is rigid like a crystal but flows without friction like a superfluid. This exotic form of quantum matter has only recently been realized in dipolar quantum gases. Researchers led by Francesca Ferlaino set out to explore how the solid and superfluid properties of a supersolid interact, particularly under rotation. In their experiments, they rotated a supersolid quantum gas using a carefully controlled magnetic field and observed a striking phenomenon: “The quantum droplets of the supersolid are in a crystal-like periodic order, all dressed by a superfluid between them”, explains ...

New gene-editing tech holds promise for treating complex genetic diseases

2025-10-23
Some genetic disorders—such as cystic fibrosis, hemophilia and Tay Sachs disease—involve many mutations in a person’s genome, often with enough variation that even two individuals who share the same disorder might have a different combination of mutations. Complexities like these make it challenging to develop broadly applicable gene therapies for these disorders. Researchers at The University of Texas at Austin now have developed an improved method of gene editing that is precise, more efficient than other similar methods and can correct many disease-causing mutations ...

Plastic pollution could linger at ocean surfaces for over a century, new research finds

2025-10-23
PRESS RELEASE EMARGOED UNTIL 08:00AM GMT, 23 OCOTBER 2025 Scientists from the Department of Geography and Environmental Science at Queen Mary University of London have developed a simple model to show how buoyant plastic can settle through the water column and they predict it could take over 100 years to remove plastic waste from the ocean’s surface. Published today in Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, the study is the third and final paper in a trilogy that explores the long-term fate of microplastic ...

TU Graz conducts research into endangered cultural heritage in the Western Himalayas

2025-10-23
In the high-altitude and extremely remote region of Dolpo in north-west Nepal, there are numerous Buddhist temples whose history dates back to the 11th century. The structures are threatened by earthquakes, landslides and planned infrastructure projects such as the Chinese Belt and Road Initiative. There is also a lack of financial resources for long-term maintenance. Researchers from the Institute of Architectural Theory, History of Art and Cultural Studies and the Institute of Engineering Geodesy and Measurement Systems at Graz University of Technology (TU Graz) want to prevent ...

LAST 30 PRESS RELEASES:

UC Irvine astronomers discover nearby exoplanet in habitable zone

New way to destroy a cancer-linked molecule revealed

Highly manipulated heterostructure via additive manufacturing

Robots that flex like US: The rise of muscle-powered machines

Obesity: A discovery shakes 60 years of certainty about fat metabolism

Guidelines for treating hereditary hearing loss with gene therapy from international experts

Chemistry: The key to civet coffee is in the chemistry

Glucagon-like peptide-1 receptor agonists and age-related macular degeneration

Prenatal exposure to fine particulate matter components and autism risk in childhood

Light exposure at night and cardiovascular disease incidence

Shining a light on heart disease risk

PAI-1 deficiency protects aging female mice from muscle and bone loss

Snake bites: How they do it

New antibody restricts the growth of aggressive and treatment-resistant breast cancers

Newly discovered ‘super-Earth’ offers prime target in search for alien life

Transport and dispersion of radioactive pollutant in the Northern South China Sea

Loneliness interventions help but are not a cure-all

Nearly 1 in 5 urinary tract infections linked to contaminated meat

FAU Engineering researchers make great ‘strides’ in gait analysis technology

One step closer to quantum computers that work properly

Common toxin linked to liver disease

Inaugural Jack Sarver Prize honors groundbreaking research by St. Louis, Dallas scientists

Two abstracts using Bronchiectasis and NTM Research Registry data presented at CHEST 2025

Decades-old asthma theory challenged: Newly discovered molecules may be real drivers of disease

Nursing faculties of Catholic universities in Japan instill unique values of compassion, dignity, and service

Dual-function molecule could unlock smarter treatments for kidney disease

Dementia linked to problems with brain’s waste clearance system

Psoriasis-linked gene mutation also impacts gut health

Widely-used technique for assessing IVF embryos may be flawed, study suggests

Alzheimer’s disrupts circadian rhythms of plaque-clearing brain cells

[Press-News.org] Dual-function molecule could unlock smarter treatments for kidney disease
Study finds the molecule CCL5 is both protective and harmful, suggesting future drugs could target only its damaging effects